Pimco Income Strategy Fund II (NYSE:PFN) Declares $0.08 Monthly Dividend

Share on StockTwits

Pimco Income Strategy Fund II (NYSE:PFN) announced a monthly dividend on Wednesday, December 4th, Wall Street Journal reports. Stockholders of record on Thursday, December 12th will be paid a dividend of 0.08 per share by the financial services provider on Thursday, January 2nd. This represents a $0.96 dividend on an annualized basis and a dividend yield of 9.13%. The ex-dividend date of this dividend is Wednesday, December 11th.

Shares of PFN stock traded up $0.02 on Wednesday, reaching $10.51. The stock had a trading volume of 194,779 shares, compared to its average volume of 185,362. The firm’s 50-day moving average is $10.52 and its two-hundred day moving average is $10.50. Pimco Income Strategy Fund II has a 12 month low of $8.88 and a 12 month high of $10.79.

Pimco Income Strategy Fund II Company Profile

PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. It is co-managed by Pacific Investment Management Company LLC. The fund invests in the fixed income markets of the United States. It invests in securities of companies operating across the diversified sectors.

Further Reading: What are high-yield dividend stocks?

Dividend History for Pimco Income Strategy Fund II (NYSE:PFN)

Receive News & Ratings for Pimco Income Strategy Fund II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pimco Income Strategy Fund II and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Analysts Set $33.00 Target Price for SpringWorks Therapeutics
Analysts Set $33.00 Target Price for SpringWorks Therapeutics
Ardelyx Inc  Given Consensus Rating of “Hold” by Analysts
Ardelyx Inc Given Consensus Rating of “Hold” by Analysts
Western Midstream Partners LP  Receives $32.25 Consensus Price Target from Analysts
Western Midstream Partners LP Receives $32.25 Consensus Price Target from Analysts
SL Green Realty Corp  Receives $93.85 Average Price Target from Brokerages
SL Green Realty Corp Receives $93.85 Average Price Target from Brokerages
HC Wainwright Reaffirms Buy Rating for Y-mAbs Therapeutics
HC Wainwright Reaffirms Buy Rating for Y-mAbs Therapeutics
Analysts Set SS&C Technologies Holdings, Inc.  Price Target at $65.91
Analysts Set SS&C Technologies Holdings, Inc. Price Target at $65.91


© 2006-2019 Ticker Report